Neuraxis Inc (NRXS) Stock Price, Quote & News

Company Profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly kno...

Industry: Biotechnology

Sector: Healthcare

Phone: 812 689 0791

Website: neuraxis.com

Address:

11611 North Meridian St, Suite 330, Carmel, United States

AshenBlade Feb. 1 at 10:43 PM

$NRXS Liquidity pressure raises questions about how long the company can operate without additional financing..

1 · Reply

AshenBlade Feb. 1 at 10:42 PM

$NRXS Gross margins have compressed due in part to discounting through patient assistance programs and inventory issues.

0 · Reply

AshenBlade Feb. 1 at 10:40 PM

$NRXS

0 · Reply

Tennis_4567 Jan. 22 at 12:58 PM

$NRXS There was some FUD going on this fall around whether or not the CPT-1 code granted this year would actually result in insurance coverage. We can officially put that to bed

0 · Reply

Tennis_4567 Jan. 22 at 12:57 PM

$NRXS

0 · Reply

trading_momentum_x Jan. 22 at 3:08 AM

$NRXS bounce off 21dema. Cup and handle still valid for now, position is back to neutral. Maintaining a 7$ PT for now

0 · Reply

SocioCobb Jan. 13 at 10:51 PM

$NRXS Just sayin'!

1 · Reply

trading_momentum_x Jan. 13 at 2:02 AM

$NRXS cup and handle play. Vpa and supply zone both have this targeted near 7$ PT

0 · Reply

JcCapital Jan. 12 at 3:04 PM

$NRXS slow riser..im loving it

0 · Reply

S144 Jan. 11 at 9:01 PM

$NRXS will cross the $5 barrier this week.

0 · Reply

NeurAxis, Inc. (NRXS) Q3 2025 Earnings Call Transcript

Nov 11, 2025, 7:00 AM EST - 2 months ago

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

Aug 12, 2025, 12:29 PM EDT - 6 months ago

NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript

Jun 17, 2025, 8:00 AM EDT - 8 months ago

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives

May 22, 2025, 1:03 PM EDT - 9 months ago

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

May 21, 2025, 7:00 AM EDT - 9 months ago

NeurAxis Announces $5.0 Million Registered Direct Offering

May 12, 2025, 1:58 PM EDT - 9 months ago

NeurAxis, Inc. (NRXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 8:15 AM EDT - 9 months ago

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

May 5, 2025, 9:00 AM EDT - 9 months ago

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025

Mar 20, 2025, 4:18 PM EDT - 11 months ago

NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 8:15 AM EDT - 11 months ago

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

Mar 12, 2025, 9:00 AM EDT - 11 months ago

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025

Jan 21, 2025, 1:45 PM EST - 1 year ago

UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States

Jan 21, 2025, 9:00 AM EST - 1 year ago

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

Jan 13, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. Issues Letter to Shareholders

Jan 6, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Nov 15, 2024, 2:04 PM EST - 1 year ago

NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:10 AM EST - 1 year ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Oct 22, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

Sep 19, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Aug 27, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

Aug 13, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

Aug 11, 2024, 5:44 AM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports Second Quarter 2024 Financial Results

Jun 7, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

May 22, 2024, 1:34 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript

May 22, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports First Quarter 2024 Financial Results

May 21, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 15, 2024, 4:30 PM EDT - 1 year ago

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

Apr 23, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New Medical Policy Coverage in North Dakota

Apr 9, 2024, 6:45 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript

Apr 9, 2024, 4:05 PM EDT - 1 year ago

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Apr 1, 2024, 4:15 PM EDT - 2 years ago

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry

Mar 11, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces Highmark BCBS Policy Coverage

Mar 4, 2024, 9:00 AM EST - 2 years ago

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

Feb 27, 2024, 11:00 AM EST - 2 years ago

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Jan 31, 2024, 9:00 AM EST - 2 years ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Dec 20, 2023, 9:00 AM EST - 2 years ago

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Nov 20, 2023, 5:30 PM EST - 2 years ago

NeurAxis Reports Third Quarter 2023 Financial Results

Nov 15, 2023, 9:00 AM EST - 2 years ago

NeurAxis Announces CareFirst BCBS Policy Coverage

Nov 14, 2023, 9:00 AM EST - 2 years ago

NeurAxis Secures $3 Million Financing

Nov 8, 2023, 9:00 AM EST - 2 years ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Reports Second Quarter 2023 Financial Results

Sep 13, 2023, 9:00 AM EDT - 2 years ago

NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

Aug 29, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Pediatric Post-Concussion Clinical Study

Aug 24, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Strength of its Board of Directors

Aug 22, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

Aug 17, 2023, 9:02 AM EDT - 2 years ago

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

AshenBlade Feb. 1 at 10:43 PM

$NRXS Liquidity pressure raises questions about how long the company can operate without additional financing..

1 · Reply

AshenBlade Feb. 1 at 10:42 PM

$NRXS Gross margins have compressed due in part to discounting through patient assistance programs and inventory issues.

0 · Reply

AshenBlade Feb. 1 at 10:40 PM

$NRXS

0 · Reply

Tennis_4567 Jan. 22 at 12:58 PM

$NRXS There was some FUD going on this fall around whether or not the CPT-1 code granted this year would actually result in insurance coverage. We can officially put that to bed

0 · Reply

Tennis_4567 Jan. 22 at 12:57 PM

$NRXS

0 · Reply

trading_momentum_x Jan. 22 at 3:08 AM

$NRXS bounce off 21dema. Cup and handle still valid for now, position is back to neutral. Maintaining a 7$ PT for now

0 · Reply

SocioCobb Jan. 13 at 10:51 PM

$NRXS Just sayin'!

1 · Reply

trading_momentum_x Jan. 13 at 2:02 AM

$NRXS cup and handle play. Vpa and supply zone both have this targeted near 7$ PT

0 · Reply

JcCapital Jan. 12 at 3:04 PM

$NRXS slow riser..im loving it

0 · Reply

S144 Jan. 11 at 9:01 PM

$NRXS will cross the $5 barrier this week.

0 · Reply

StockScubaDiver Jan. 9 at 7:06 PM

$NRXS

0 · Reply

Andyc545 Jan. 9 at 5:38 PM

$NRXS Break8hg the lid right off!

0 · Reply

Tennis_4567 Jan. 8 at 5:07 PM

$NRXS if anyone was considering buying this, but feels the price has run away/ too late to enter… I have news. This is still tremendously cheap if you’re time frame for holding is 1-2 years.

0 · Reply

WarriorSTC Jan. 8 at 1:08 PM

$NRXS https://www.stocktitan.net/news/NRXS/neur-axis-achieves-major-milestone-with-ama-category-i-cpt-code-now-bl54top5017f.html

0 · Reply

Finnish_boy Jan. 8 at 1:08 PM

$NRXS Webcast January 15th

0 · Reply

Finnish_boy Jan. 8 at 1:07 PM

$NRXS https://ir.neuraxis.com/news-releases/news-release-details/neuraxis-achieves-major-milestone-ama-category-i-cptr-code-now @Tennis_4567 Not news but press release

1 · Reply

trading_momentum_x Jan. 5 at 3:04 AM

$NRXS not counting the cup and handle pattern invalid just yet. Couple mini doji candles last few days looks to be ready to make a decision soon neither direction

0 · Reply

S144 Jan. 4 at 4:13 PM

$NRXS "NeurAxis Escalates Commercial Rollout": https://microcapopportunities.substack.com/p/neuraxis-escalates-commercial-rollout NeurAxis has five salespeople serving the pediatric market. NRXS has assigned five salespeople to commercialize the VA (Veterans Affairs) opportunity. There are about 7 million active VA patients who will provide NRXS with a secondary revenue stream as early as this quarter. @alexpitti : No brainer buy, right ?

1 · Reply

Lockedin2024 Jan. 2 at 7:39 PM

$NRXS stock is so slept on... easily $7 soon

0 · Reply

TruthTooPower Jan. 2 at 2:14 PM

$NRXS!!! Watch This Mother Blow Up at Open!!!

0 · Reply

SuperGreenToday Dec. 31 at 7:22 PM

$NRXS

0 · Reply

Boomer52 Dec. 31 at 2:22 PM

$NRXS What the chart tell you? I see a lot of big upper candle wicks.

0 · Reply

Market Cap	45.06M
Revenue (ttm)	2.69M
Net Income (ttm)	-8.24M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-306.32%
Debt to Equity Ratio	0.00

Volume	44,000
Avg Vol	421,698
Day's Range	N/A - N/A
Shares Out	10.65M
Stochastic %K	24%
Beta	2.80
Analysts	Strong Sell
Price Target	$8.00